Joseph K. Belanoff - 31 Dec 2024 SCHEDULE 13G/A Report for Corcept Therapeutics Incorporated Common Stock (CORT)

Filing Manager: Joseph K. Belanoff
Reporting Manager: Joseph K. Belanoff
Security: Corcept Therapeutics Incorporated Common Stock
Symbol: CORT
Shares outstanding: 108,291,032 shares
Disclosed Ownership: 6,822,335 shares
Ownership: 6.3%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 21:08:28 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Joseph K. Belanoff	6.3%	6,822,335	3,800,000	3,022,335	/s/ Joseph K. Belanoff	Chief Executive Officer